65 i b, drugs, pharmaceuticals,&hematology related products, FSS contract award
Ended Awarded Last action
- Contract number
- 36F79719D0153
- Awardee
-
Genzyme Corporation UEI X2XMAQLR9DA8
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 19
Award facts
- Opportunity
-
- 65IB Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $659,734,240.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
GSA issued the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) to Genzyme Corporation on May 15, 2019, a multiple-award catalog-based vehicle with a $659.7 million ceiling enabling the Department of Veterans Affairs Veterans Health Administration to place delivery orders for specialty pharmaceutical products nationwide without conducting individual competitions.
Genzyme operates under the Sanofi Genzyme division brand. The schedule covers a broad portfolio of pharmaceutical and hematology-related products, with Genzyme's ordering activity concentrated on specialty cancer drugs and rare-disease therapeutics including Eliglustat (Cerdelga), Lemtrada, and Caprelsa (vandetanib). Delivery orders are firm fixed price, issued by Veterans Integrated Service Networks (VISNs) 1, 16, 20, 21, and 22 across VA medical centers nationwide. Place of performance spans Cambridge, Massachusetts; Seattle, Washington; San Diego, California; Cary, North Carolina; Pittsburgh, Pennsylvania; and Deerfield, Illinois. Recent ordering under this Schedule includes delivery orders ranging from emergency pharmaceutical procurements (such as a $40.7 thousand Caprelsa order in May 2020) to bulk purchases exceeding $240 thousand, with performance periods spanning weeks to over one year.
Two related blanket purchase agreements for specific drugs under this parent Schedule are also active: a $3.0 million single-award BPA for Cerdelga, Caprelsa, and Lemtrada awarded June 6, 2024 with completion June 5, 2027; and a $4.0 million single-award BPA for Lemtrada and Cerdelga awarded May 17, 2019, updated in 2024 for public law pricing, with completion May 16, 2024.
Task orders
Show all 19
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36E79724A0018 | National Acquisition Center (VA) | $3,000,000 | |
| 36E79719A0021 | National Acquisition Center (VA) | $4,036,157 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Legal Contract Cancellation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 |
Show 40 more
Latest 50 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract 36F79719D0153?
36F79719D0153 was awarded to Genzyme Corporation by Veterans Integrated Service Network 12 (Veterans Health Administration) on May 15, 2019.
How much is contract 36F79719D0153 worth?
36F79719D0153's own ceiling is $659,734,240.
How many orders have been placed under contract 36F79719D0153?
19 orders have been placed under 36F79719D0153, the latest on November 20, 2023.
Who can order from contract 36F79719D0153?
36F79719D0153 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79719D0153 part of a contract vehicle?
Yes. 36F79719D0153 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79719D0153 competed?
The extent of competition for 36F79719D0153 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV